X-ray-endovascular interventions in the treatment of patients with liver metastases of colorectal cancer after the termination of systemic chemotherapy
Journal of Clinical Practice · 2022-07-03 · 13 (2) · 59-65
DOI: 10.17816/clinpract108552 ↗At a glance
Journal article in Journal of Clinical Practice, published online on 2022-07-03. Written by Oksana Yu. Stukalova and 3 co-authors. Cited 3 times so far (Crossref); 14 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Topics: Onkologische Pflege
Abstract (original language)
Background
At present, the problem of treating common forms of colorectal cancer does not lose its relevance due to the increase in its incidence. Systemic chemotherapy is the main line of treatment for patients with unresectable liver metastases. However, a significant problem of modern oncology is the further treatment tactics for patients with chemoresistant metastases. Aims: to improve the treatment results for patients with chemoresistant liver metastases of colorectal cancer.
Method
36 patients with unresectable liver metastases of colorectal cancer were treated at the Granov Russian Research Center of Radiology and Surgical Technologies and the RZD-Medicine Central Clinical Hospital. For all the patients, systemic chemotherapy was considered unreasonable due to the development of chemoresistance or a high degree of toxicity. The patients underwent regional chemotherapy chemoinfusion and/or chemoembolization of the hepatic artery.
Results
The treatment evaluation was performed using the RECIST 1.1 scale. After 6 months, a partial response was reached in 1 patient (2.8%), stabilization was observed in 29 (80.5%) patients, and 6 patients (16.7%) had the disease progression. In 2 (5.6%) cases, a lethal outcome was observed against the background of the systemic progression of the oncological disease. One year later, stabilization of the malignant process was detected in 21 (58.3%) cases, progression was detected in 15 (41.7%) cases. A one-year survival of patients was 83.3%, the overall survival 22 months.
Conclusion
The use of interventional radiology methods has shown its effectiveness in patients with unresectable chemoresistant liver metastases of colorectal cancer.
Cite
APA
Stukalova, O. Y., Polikarpov, A. A., Ishchenko, R. V., & Shugushev, Z. K. (2022). X-ray-endovascular interventions in the treatment of patients with liver metastases of colorectal cancer after the termination of systemic chemotherapy. Journal of Clinical Practice, 13(2), 59-65. https://doi.org/10.17816/clinpract108552
Vancouver
Stukalova OY, Polikarpov AA, Ishchenko RV, Shugushev ZK. X-ray-endovascular interventions in the treatment of patients with liver metastases of colorectal cancer after the termination of systemic chemotherapy. Journal of Clinical Practice. 2022;13(2):59-65. doi:10.17816/clinpract108552
BibTeX
@article{Stukalova2022,
author = {Stukalova, Oksana Yu. and Polikarpov, Aleksey A. and Ishchenko, Roman V. and Shugushev, Zaurbek Kh.},
title = {X-ray-endovascular interventions in the treatment of patients with liver metastases of colorectal cancer after the termination of systemic chemotherapy},
journal = {Journal of Clinical Practice},
year = {2022},
volume = {13},
number = {2},
pages = {59--65},
doi = {10.17816/clinpract108552}
}
EUVIMED